Country: Israel
Language: English
Source: Ministry of Health
TESTOSTERONE
PADAGIS ISRAEL PHARMACEUTICALS LTD, ISRAEL
G03EA02
GEL
TESTOSTERONE 50 MG/DOSE
TRANSDERMAL
Required
PADAGIS ISRAEL PHARMACEUTICALS LTD, ISRAEL
TESTOSTERONE AND ESTROGEN
TESTOSTERONE AND ESTROGEN
Testosterone replacement therapy for males hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
2022-02-28
Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT: TESTOMAX 50 mg TESTOMAX 25 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION: TESTOMAX 50 mg: Testosterone 0.05 g per 5 g sachet TESTOMAX 25 mg: Testosterone 0.025 g per 2.5 g sachet For excipients, see 6.1. 3. PHARMACEUTICAL FORM: Gel Clear, transparent colorless gel . 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Testosterone replacement therapy for males hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests. 4.2 POSOLOGY AND ADMINISTRATION ROUTE Cutaneous use _Adults and elderly _ The recommended dose is 5 g of gel (i.e. 50 mg of testosterone) applied once daily, at about the same time, preferably in the morning. The daily dose should be adjusted by the doctor depending on the clinical or laboratory response in individual patients, not exceeding 10 g of gel per day. The adjustment of posology should be achieved by 2.5 g of gel steps. The application should be administered by the patient himself, onto clean, dry, healthy skin over the shoulders, or both arms or abdomen. After opening the sachet, the total content must be extracted from the sachet and applied immediately onto the skin. The gel has just to be simply spread on the skin gently as a thin layer. It is not necessary to rub it on the skin. Allow drying for at least 3-5 minutes before dressing. Wash hands with soap and water after applications. Do not apply to the genital areas as the high alcohol content may cause local irritation. Steady state plasma testosterone concentrations are reached approximately on the 2 nd day of treatment with Testomax. In order to adjust the testosterone dose, serum testosterone concentrations must be measured in the morning before application from the 3 rd day on after starting treatment (one week seems reasonable). The dose may be reduced if the plasma testosterone concentrations are raised above the desired level. If the concentrations are low, the dosage may be increased, not exceeding 1 Read the complete document